Continuing to advance the globalization strategy (Issue Ⅳ) | Keyuan Pharma appeared at CPHI Japan and In-Cosmetics Europe (Netherlands)
In order to accelerate the globalization layout and expand the international market, Keyuan Pharma with flagship products appeared in two international authoritative exhibitions, CPhI Japan and In-Cosmetics Global to demonstrate technological strength in the field of pharmaceutical API and cosmetics ingredients, and further promote international cooperation and industrial cooperation.
As one of the vanes in the global pharmaceutical industry, CPHI attracts companies, research institutions and experts from all over the world every year to discuss the latest trends and innovations. Chunpo Gao, Chairman and President, led the team to talk about business with new and old customers to further deepen future market expansion and business cooperation. By showcasing core products in the fields of anti-diabetic drugs, cardiovascular and cerebrovascular drugs, anesthetics, etc., as well as advantages in R&D, production, quality control and other aspects, Keyuan Pharma attracted the attention of many potential customers.
At the same time, the international cosmetics raw material exhibition was held in Netherlands, attracted cosmetic raw material suppliers, manufacturers and brand owners from all over the world. Keyuan Pharma demonstrated R&D results and product advantages at the exhibition, established connections with international customers, and laid the foundation for expansion in the cosmetic raw material market.
In recent years, Keyuan Pharma has pushed forward internationalization strategy in depth and achieved remarkable results, gradually built a marketing network covering Europe, America, and Asia Pacific through international certification and marketing cooperation, improving core competitiveness and international influence, cooperative customers are spread across more than 20 countries around the world.
This dual exhibition linkage is a key step to implement global strategy. Keyuan Pharma will continue to increase investment in R&D innovation, international expansion and other aspects to enhance comprehensive strength and market position, take this exhibition as an opportunity to deepen operations, further strengthen cooperation with international customers, promote Chinese high-end raw materials to the world, and provide better quality pharmaceutical products for patients around the world.